- Home
- HTLD vs EYPT Comparison
HTLD vs EYPT Comparison
Compare HTLD & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HTLD
- EYPT
- Stock Information
- Founded
- HTLD 1978
- EYPT 1987
- Country
- HTLD United States
- EYPT United States
- Employees
- HTLD N/A
- EYPT N/A
- Industry
- HTLD Trucking Freight/Courier Services
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- HTLD Industrials
- EYPT Industrials
- Exchange
- HTLD Nasdaq
- EYPT Nasdaq
- Market Cap
- HTLD 622.9M
- EYPT 741.0M
- IPO Year
- HTLD N/A
- EYPT 2005
- Fundamental
- Price
- HTLD $8.39
- EYPT $13.24
- Analyst Decision
- HTLD Hold
- EYPT Strong Buy
- Analyst Count
- HTLD 5
- EYPT 6
- Target Price
- HTLD $9.50
- EYPT $25.83
- AVG Volume (30 Days)
- HTLD 657.1K
- EYPT 1.1M
- Earning Date
- HTLD 10-28-2025
- EYPT 11-06-2025
- Dividend Yield
- HTLD 0.92%
- EYPT N/A
- EPS Growth
- HTLD N/A
- EYPT N/A
- EPS
- HTLD N/A
- EYPT N/A
- Revenue
- HTLD $932,244,000.00
- EYPT $51,898,000.00
- Revenue This Year
- HTLD N/A
- EYPT N/A
- Revenue Next Year
- HTLD $4.57
- EYPT N/A
- P/E Ratio
- HTLD N/A
- EYPT N/A
- Revenue Growth
- HTLD N/A
- EYPT 2.99
- 52 Week Low
- HTLD $7.11
- EYPT $3.91
- 52 Week High
- HTLD $12.85
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- HTLD 47.14
- EYPT 51.60
- Support Level
- HTLD $8.16
- EYPT $12.54
- Resistance Level
- HTLD $8.84
- EYPT $14.04
- Average True Range (ATR)
- HTLD 0.23
- EYPT 0.86
- MACD
- HTLD -0.00
- EYPT -0.13
- Stochastic Oscillator
- HTLD 33.33
- EYPT 24.05
About HTLD Heartland Express Inc.
Heartland Express Inc is engaged in providing truckload services across the United States, Mexico, and Canada. These truckload services are asset-based transportation services in the dry van truckload market. The company offers truckload temperature-controlled transportation services, and Mexico logistics services. A majority of its customers represent the consumer goods, appliances, food products, and automotive industries.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.